Diagnostic Accuracy of<sup>68</sup>Ga-FAPI Versus<sup>18</sup>F-FDG PET in Patients with Various Malignancies
Nader Hirmas(German Breast group), Wolfgang P. Fendler(Essen University Hospital), Stefan Kasper(Essen University Hospital), Claudia Kesch(Essen University Hospital), Lukas Kessler(Düsseldorf University Hospital), Miriam Sraieb(Deutsches Konsortium für Translationale Krebsforschung), Bastian von Tresckow(University of Cologne), Kim M. Pabst(West German Heart and Vascular Center Essen), Helena Lanzafame(Essen University Hospital), Martin Stuschke(Essen University Hospital), Jens T. Siveke(German Cancer Research Center), Céline Lugnier(Ruhr University Bochum), Hubertus Hautzel(Deutsches Konsortium für Translationale Krebsforschung), Boris Hadaschik(Essen University Hospital), Rainer Hamacher(Essen University Hospital), Philipp Harter(Kliniken Essen-Mitte), Michael Nader(Klinik und Poliklinik für Nuklearmedizin), Waldemar Uhl(St. Josef-Hospital), Clemens Aigner(Comprehensive Cancer Center Vienna), Francesco Barbato(Deutsches Konsortium für Translationale Krebsforschung), Ken Herrmann(Essen University Hospital), Martin Glas(Essen University Hospital), Sherko Kümmel(Kliniken Essen-Mitte), Viktor Grünwald(Deutsche Schmerzgesellschaft)
Cited by 31
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression
|Oral Oncology|2018|802
IAP Guidelines for the Surgical Management of Acute Pancreatitis
|Pancreatology|2002|774